Cosmetic surgery market analysis by gender, age group, procedure, end user and region; 2024 to 2032

Dublin, June 17, 2024 (GLOBE NEWSWIRE) — The “Cosmetic Surgery Market Report by Gender, Age Group, Procedure, End User, Regions and Company Analysis 2024-2032” report has been added to the ResearchAndMarkets.com’s The offer of

The Global Cosmetic Surgery Market is projected to be worth USD 164.22 billion by 2032. The CAGR for the global cosmetic surgery market during 2024-2032 is projected to be 9.95%. The market will be valued at $69.93 billion in 2023.

AbbVie Inc., Cutera Inc., Sientra Inc., Bausch Health Companies Inc., Johnson & Johnson Services, Inc., Apyx Medical, Hologic, Merz Pharma, Galderma, and Cynosure are the leading businesses in the global cosmetic surgery market.

More than 14.9 million surgical operations and 18.8 million non-surgical operations will be performed globally by plastic surgeons in 2022, according to a report by the International Society of Aesthetic Plastic Surgery (ISAPS), which predicts an 11.2% increase in procedures overall.

Global Cosmetic Surgery Market Trends

• Increasing youth awareness about cosmetic surgery is a major factor driving the expansion of the worldwide cosmetic surgery market. The story that young people tell about cosmetic surgery has changed significantly in recent years. This change is explained by the increasing variety of media in the representation of beauty, the influence of social media influencers and access to more information.
• The American Society of Plastic Surgeons (ASPS) reports that in 2022, 244,252 minimally invasive cosmetic treatments were also performed, and 23,527 cosmetic surgery procedures were performed on patients who were 19 years of age or younger.
• The global cosmetic surgery industry has experienced a real revolution due to continuous technological improvements. Procedures are now safer, more precise and effective than ever due to advances in robotic surgery, virtual reality, non-surgical procedures, 3D imaging and printing.
• In 2021, the subsidiary of AbbVie Inc. Allergen Aesthetics unveiled Coolsculpting Elite, a next-generation fat removal technology. Its applicators are designed to emphasize the natural curves of the body.
• The cosmetic surgery market has also been aided by the rise in numerous skin problems caused by current lifestyle choices.
• 1.8 billion people worldwide are thought to be affected by skin problems at any given time, according to WHO statistics.

Asia-Pacific Cosmetic Surgery Market

• The global cosmetic surgery market is being driven by the booming medical tourism sector in Asia Pacific. Important Asia-Pacific nations such as China and India have made a name for themselves as desirable destinations for medical tourism involving a variety of operations, including cosmetic surgeries.
• 5.04 lakh medical tourists came to India in 2023, according to the Ministry of Tourism.
• Credit rating agency Crisil has released statistics showing that the number of medical tourists expected to visit India in calendar year (CY) 2024 will be approximately 7.3 million, up from a forecast of 6.1 million in CY 2023.
• Cosmetic surgeries such as facelifts, rhinoplasty, breast augmentation and liposuction attract medical tourists to countries such as South Korea, Thailand and Malaysia.
• The Ministry of Health and Welfare released data showing that last year, South Korean medical facilities treated 605,768 international patients (not including repeat visits). Compared to 2022, this is a 2.4 times increase (144.2%).
• More than half of medical tourists received dermatological treatments (35.2%) and plastic surgery (16.8%). As of 2022, there has been a 2.6-6.6 times increase in the number of international patients undergoing dermatology treatments, traditional Korean medicine treatments, and general health examinations.
• Increasing emphasis on aesthetic appearances and aging population in Asia Pacific contribute to the growth of the cosmetic surgery market.

Global cosmetic surgery industry news

• In January 2024 – Leading healthcare investment banker Viper Partners has announced that it will provide exclusive sell-side advisory support in the acquisition of Wave Plastic Surgery and Aesthetic Laser Center (“Wave”). Wave, located in the central region of California, is much more than just a standard plastic surgery facility.
• In October 2023 – Marena Group revealed that they have joined forces with suit:match.ai, a digital company, to introduce an AI-powered body scanning software that helps plastic surgeons in clinics match their patients with clothes better after surgery. suit them.
• In August 2023 – Bimini Health Tech recently created a subsidiary that purchased nearly all of the assets of Ideal Implant, Inc., including product inventories, regulatory approvals, intellectual property and some manufacturing capacity. Consequently, Puregraft fat transfer technology, an Acellular Dermal Matrix (ADM), a breast implant, and the Healeon PRP product line are now part of Bimini Health Tech’s portfolio.
• In March 2023 – To launch Mia Femtech, Establishment Labs Holdings Inc. revealed that it is working with four European partners, as well as a diverse network of partners in Japan. This innovative device uses a short 15-minute treatment to improve breast shape.
• In June 2022 – The PicoSure Pro device, which Cynosure introduced, has a unique focusing array of platinum lenses. This last technique aims to increase the amount of elastin and collagen. For smoother, more youthful skin, it successfully minimizes pore size, wrinkles and acne scars.

Gender – Splitting the market into 2 perspectives:

1. Female
2. On the contrary

Age group – Dividing the market into 3 perspectives:

1. 13 to 29
2. 30 to 54
3. 54 and above

Procedure – Dividing the market into 2 perspectives:

1. Surgical procedure
2. Non-surgical procedure

End user – Market division into 3 perspectives:

1. Outpatient Surgical Facility
2. Hospital and Clinic
3. Official and Cosmetic Surgery Center

Country – Market division of 5 regions and 25 countries:

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. The Middle East and Africa

Company Analysis:

1. AbbVie Inc.
2. Cutera Inc.
3. Sientra Inc.
4. Bausch Health Companies Inc.
5. Johnson & Johnson Services, Inc.
6. Apyx Medical
7. Hological
8. Merz Pharma
9. Galderma
10. Cynosure

All players are covered from 4 perspectives:

• General overview
• Recent developments
• Product portfolio
• Financial Insights

Main attributes

The report attribute	The details
No. of Pages	215
Forecast period	2023-2032
Estimated market value (USD) in 2023	69.93 billion dollars
Projected market value (USD) by 2032	164.22 billion dollars
Compound annual growth rate	9.9%
Regions covered	global

For more information about this report, visit https://www.researchandmarkets.com/r/yvbf48

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.